BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS










 Company News
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014 5:55:41 AM
Boehringer Ingelheim Corporation Release: First Patients Enrolled In Study To Evaluate Dabigatran Etexilate After PCI With Stenting 8/19/2014 10:19:19 AM
FDA Tentatively Approves Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Basaglar™ 8/18/2014 3:54:05 PM
Boehringer Ingelheim Corporation Goes On A Hiring Freeze And Plans To Chop Jobs 8/12/2014 6:13:33 AM
Medivir AB (MVRBF) Licenses Respiratory Syncytial Virus Drug Program From Boehringer Ingelheim Corporation 8/4/2014 11:04:25 AM
FDA Green Lights Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes 8/1/2014 11:08:18 AM
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014 9:06:40 AM
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014 9:12:38 AM
Boehringer Ingelheim Corporation's Investigational Therapy Nintedanib Receives FDA Breakthrough Therapy Designation 7/16/2014 10:38:47 AM
Boehringer Ingelheim Corporation's Breakthrough Cancer Drug Volasertib Effective In Phase 2 Trial 7/8/2014 8:38:37 AM
12345678910...